MYC and Miyoshi myopathy: As our data, together with previous in vitro and in vivo results with human samples9,30–32, suggested a role for IL-17 in favoring MM aggressiveness, we backcrossed Vk*MYC mice into IL-17KO congenic mice, and monitored them for disease occurrence.